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Abstract 
Objectives: The purpose of this study was to compare the clinical and radiographic features of 22 intraosseous 
ameloblastomas. Study design: All the data with respect to the patient’s age, sex, tumor locations, surgical 
treatment history, as well as radiographic findings and number of recurrence, were analyzed. Results: The patient’s 
age at biopsy ranged from 08 to 70 years (mean, 31.5 years), Fourteen (63.6%) of the 22 subjects were females, 
and eight (36.4%) were males. Nineteen (86.4%) of the 22 ameloblastomas were located in mandible and three 
(13.6%) were located in maxilla. Pain, swelling and purulent discharge were the most common symptoms and 
were experienced by eight (36.4%) patients. Radiographically, seventeen (77.3%) of the 22 tumors were 
multilocular. Remaining five cases were unilocular with a well-demarcated border. There was no case exhibiting 
the typical soap-bubble appearance. The most common histologic pattern was plexiform and had follicular type. 
Conclusion: Diagnosis of ameloblastoma remained in doubt after clinical and radiographic examination. A biopsy 
is necessary for the confirmation of diagnosis. Surgical treatment should be planned after C.T and 3D Scan. Long-
term follow-up at regular intervals after surgery is also recommended. 
Keywords: Ameloblastoma, Diagnosis, Radiographic 
DOI: 10.7176/JMPB/60-02 
Publication date:October 31st 2019 
 
Introduction 
Ameloblastomas are an enigmatic group of oral tumors. The general agreement that ameloblastomas are 
odontogenic in origin occurs largely on the basis of the histological similarities of the tumor and the developing 
enamel organ. (1-5)  Ameloblastomas in young people (i.e., those 19 years old and younger) are thought to be rare. 
They account for approximately 10% to 15% of all reported cases of ameloblastoma.(6,7)  Several causative factors 
have been proposed, including (1) nonspecific irritating factors such as extraction, caries, trauma, infection, 
inflammation, or tooth eruption; (2) nutritional deficit disorders; and (3) viral pathogenisis. (8). The pathology of 
ameloblastoma is generally well understood and includes the importance of separating this tumor into three types, 
each with its own distinctive clinical behavior and response to treatment. Two factors are of major important 
concerning the biologic behavior and therefore the treatment of classic intraosseous ameloblastoma. The first is 
that it infiltrates cancellous bone but is largely confined by compact bone; the second is the location of the tumor 
within the jaw. Ameloblastoma has a well-deserved reputation for recurrence after curettage. Gold’s well-reasoned 
argument that the ameloblastoma should be considered a low-grade malignant tumor should be noted. (9) This 
infiltration of cancellous bone has two important consequences clinically. First, the tumor extends beyond its 
radiologically apparent margin. Second, recurrence is to be expected if the clinician accepts the radiologic margin 
of the tumor in cancellous bone as its actual limit and creates the lesion on that basis. Consequently, attempts have 
been made to remove any tumor that has extended beyond its radiologic margins by the use of various forms of 
cautery or by removing bone from the surgical cavity with a bur (peripheral ostectomy).  The location of 
ameloblastoma in the jaw is important. First, the farther the tumor is from vital structures, the less likely it is to 
infiltrate them. It follows that ameloblastomas of the body of mandible and of the anterior maxilla are less 
dangerous than those of the ascending ramus and especially those of the posterior maxilla. Secondly, the entire 
maxilla, unlike the mandible, possesses a very thin cortical plate; moreover, the layers of bone between the apices 
of the posterior teeth and the floor of the maxillary sinus are often extremely thin. Consequently, the maxilla does 
not possess the effective barrier to the spread of ameloblastoma that a thick cortical plate provides, and the 
ameloblastoma can therefore readily spread into adjacent structures. Complete excision, including removal of an 
extensive margin of apparently unaffected bone, is also the standard treatment for mandibular ameloblastomas. 
Unicystic ameloblastomas generally resemble dentigerous cysts clinically and radiologically. They typically occur 
more often in younger persons, mainly in the second and third decades of life, than do classic intraosseous 
ameloblastomas. (10-11)  
The diagnosis of unicystic ameloblastoma is based on two features. First, the lesion must be unilocular, 
clinically and radiologically. Second, on microscopic examination it must appear as a single cystic lesion with the 
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epithelial lining consisting of ameloblastoma. The importance of the unicystic ameloblastoma is that it possesses 
a much better prognosis after enucleation or curettage than does the classic intraosseous ameloblastoma. (10-14) 
The reason for this better prognosis is that in many examples the ameloblastoma involves only the epithelial lining 
of the cyst or project into its lumen. Its recurrence rate after these procedures is around 15%, whereas recurrence 
is much higher after curettage of classic intraosseous ameloblastoma. These lesions, which are sometimes referred 
to as luminal or intraluminal ameloblastomas, respectively, are confined by the fibrous connective tissue wall of 
the cyst and are consequently removed completely if the cyst is enucleated. Theoretically, they do not recur.  
However, other unicystic ameloblastomas may recur. They are the so called mural ameloblastomas that have 
involved the connective tissue wall of the cyst from their origin in the epithelial lining of the cyst, or possibly they 
have arisen from rests of odontogenic epithelium within the wall of the cyst and that have subsequently invaded 
the surrounding bone. At this stage, a unicystic ameloblastoma will act as a classic intraosseous ameloblastoma 
and has to be treated as such. A unicystic ameloblastoma only enjoys a good prognosis if it is still confined within 
the fibrous connective tissue wall of the cyst. 
The peripheral ameloblastoma is defined as an ameloblastoma that is confined to the gingival or alveolar 
mucosa. It infiltrates the surrounding tissues, basically the gingival connective tissue, like any other ameloblastoma 
but it does not invade the underlying bone. The peripheral ameloblastoma is readily cured by complete excision 
including a microscopically proven tumor-free zone of tissue surrounding the tumor’s lateral and deep margins. 
There are two major reasons why the peripheral ameloblastoma has a good prognosis. First it appears as a gingival 
growth and as such it is readily noticeable; it is therefore normally excised early in its development. The second 
reason is that the cortical bone of the jaws, which represents such a barrier to the classic intraosseous 
ameloblastoma’s breaking out of bone, is just as efficient a barrier to the invasion of the jaw by a peripheral 
ameloblastoma. In addition, the dense fibrous connective tissue of the gingiva probably provides more resistance 
to the spread of tumor than does the delicate connective tissue of the intertrabecular spaces of cancellous bone. 
Desmoplastic ameloblastoma is a new development. The islands of ameloblastoma are surrounded and often 
compressed by a dense and sometimes hyalinized fibrous connective tissue. The desmoplastic ameloblastoma 
involves the anterior maxilla predominantly, which is an unusual location for ameloblastoma although it also 
involves the anterior mandible quite commonly, and presents a radiographic appearance that is more typical of a 
benign fibroosseous lesion than of ameloblastoma. 
Almost all ameloblastomas are cytologically benign, but very occasionally a lesion that is otherwise 
microscopically a typical ameloblastoma exhibits cytologic evidence of a malignant condition. Such tumors are 
referred to as ameloblastic carcinomas as opposed to malignant ameloblastomas; the latter are cytologically benign 
tumors that unexpectedly metastasize and are so rare as to be considered curiosities. 
 
SUBJECTS AND METHODS 
Twenty-two patients with ameloblastoma were treated at our hospital between January 2003 and September 2004. 
All clinical and radiological information with respect to age, sex, symptoms, and location were verified. The 
patients were treated conservatively (i.e., with enucleation, curettage and peripheral ostectomy) or radically (i.e., 
with partial jaw resection). Histology slides from each case were reviewed and classified according to histological 
patterns. 
 
RESULTS 
The study group consisted of 8 males and 14 females with a mean age of 31.6 years (8-70 years; Table I and II). 
In 19 cases (86.4%), the tumor was located in the mandible, and in 3 cases (13.6%), the tumor was located in 
maxilla. Of the 19 mandibular lesions, 13 (59.1%) were located in the mandibular body and ramus (Table III). 
Pain, swelling and purulent discharge were the most common symptoms, experienced by 8 (36.4%) of the 22 
patients (Table IV). Second most common symptom was pain and swelling experienced by 7 (31.8%), and swelling 
was observed only in 6 (27.3%) out of the 22 patients. Radiographically, 5 (22.7%) of the 22 cases were unilocular 
with a well-demarcated border, whereas 17 (77.3%) were multilocular in appearance (Table V). There was no case 
that exhibited a soap-bubble appearance.  
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Graph-1: Percentage of patients according to gender 
 
 
Graph-2: Frequency distribution of age groups 
 
 
Graph-3: Percentage of complaints 
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Graph-4: Frequency distribution of sites of ameloblastoma 
 
 
DISCUSSION 
It has been reported previously that unilocular ameloblastomas tend to occur in younger age groups. Our results 
confirmed this tendency. In unilocular ameloblastoma, 4 (80%) out of 5 cases occurred in teenage group. It was 
also reported that ameloblastoma in young people (i.e., those of 19 years old and younger) are 10% to 15% of all 
reported cases of ameloblastoma. (6,7) Our study has not confirmed this tendency. There were 8 (36.4%) cases of 
ameloblastomas which occurred in teenage group. The average age of patients with intraosseous ameloblastoma 
has been reported to be 39 years. In this study, we documented the occurrence of ameloblastomas in a significantly 
younger age group i.e., 16 (72.7%) cases of ameloblastomas out of total 22 cases. The mean age of our patients at 
biopsy was 30.6 years (Table I). This variation may reflect ethnic differences or diagnosis within a health care 
system. Waldron and El-Mofty(15) reported that in 116 tumors, the male-to-female ratio was 1.2:1, which is in 
contrast to our results. In our study male-to-female ratio is 1:1.8, which is quite variation to the literature (Table 
I). Our studies show that ameloblastomas have a marked predilection for the mandible (86.4%). 
Pain, swelling and purulent discharge accounts for 36.4% of the symptoms and was the most common 
complaint of the patients in this study. Ameloblastomas are treated by curettage only, enucleation, peripheral 
ostectomy and radical surgery. (14,16) Ameloblastoma of the maxilla should be treated as radically as possible. 
However, ameloblastoma that appears as unilocular lesions radiographically may be treated conservatively (i.e., 
with enucleation or curettage, or both) whereas all areas of the cystic lumen can be controlled intraoperatively. 
Supraperiosteal resection of the bone is necessary when extensive thinning or perforation of the cortical plates is 
noted. Chemotherapy and radiation seem to be contraindicated. (14). Postoperative follow-up is important in the 
management of ameloblastoma because more than 50% of all recurrence occurs within 5 years of surgery. In 
contrast to other reports, we found that most ameloblastomas occurred in the 3rd decade of life. Long-term follow-
up at regular intervals after surgery is also recommended. 
 
Conclusion:  
Diagnosis of ameloblastoma remained in doubt after clinical and radiographic examination. A biopsy is necessary 
for the confirmation of diagnosis. Surgical treatment should be planned after C.T and 3D Scan. Long-term follow-
up at regular intervals after surgery is also recommended. 
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